et al.. p21-Activated kinase mediates rapid estradiol-negative feedback actions in the reproductive axis..
O
varian estradiol-17␤ (E 2 ) conveys negative feedback actions within the reproductive axis that include inhibition of gonadotropin-releasing hormone (GnRH) neurosecretion and suppression of gonadotrope responsiveness to GnRH stimulation. Both actions can be sustained by E 2 treatment regimens that maintain serum E 2 levels in low physiological ranges (1) and they can also be manifested rapidly, within minutes after E 2 injection (2). Studies of estrogen receptor ␣ (ER␣), ER␤, and ER␣/␤ null mutant mice have clearly implicated ER␣ as the isoform essential for E 2 negative feedback regulation in vivo (3, 4) .
Cell signaling pathways that transduce ER␣-mediated negative feedback are not well understood. In classical ER␣ signaling mechanisms, E 2 binds nuclear ERs and recruits coactivators to consensus palindromic estrogen response elements (EREs). Direct binding of ERs to EREs thereby mediates alterations in transcription of target genes. Nonclassical ER␣ signaling mechanisms operate independently of ER␣ binding directly to EREs and include protein-protein interactions with transcription factors, such as AP1, SP1, and NF-B (5), which in turn mediate transcriptional regulation at their cognate response elements. Nonclassical ER␣ signaling also includes membrane-associated receptor activation coupled to stimulation of cytoplasmic signaling pathways. To distinguish relative contributions of classical versus nonclassical ER␣ signaling to E 2 actions in vivo, Jakacka et al. (6) developed a gene knockin mouse that expresses a mutant (E207A/G208A; AA) form of ER␣ with disrupted classical (ERE-dependent) but intact nonclassical (EREindependent) ER␣-signaling capacities. By using animals in which the AA mutant allele was introduced onto the ER␣-null (ER␣ Ϫ/Ϫ ) mutant background (ER␣ Ϫ/AA mice), we determined that nonclassical ER␣ signaling can rescue the majority of E 2 negative feedback effects that are present in wild-type (ER␣ ϩ/ϩ ) mice and completely absent in ER␣ Ϫ/Ϫ mice (7) .
Here, we attempt to identify a downstream mediator of nonclassical ER␣ signaling mechanisms conveying E 2 negative feedback in the brain. E 2 can modulate dendrite morphogenesis and induce synaptogenesis in hypothalamic (8) (9) (10) (11) and extrahypothalamic neuronal populations (12, 13) , and such structural plasticity may mediate E 2 feedback effects (14) . That the ER␣ isoform appears to mediate many of these effects rapidly (15) is consistent with the idea that membrane-initiated, nonclassical ER␣ signaling can rapidly induce the actin-cytoskeletal reorganization required for synaptic remodeling (16) . In nonneural cells, ER␣ signaling produces rapid alterations in cell shape, polarity, and motility by activating p21-activated kinase 1 (PAK1) (17) , the best-characterized member of a family of conserved mammalian serine/threonine kinases that function as downstream effectors of activated Rho GTPases, Rac1 and Cdc42, as well as phosphatidylinositol 3-kinase (PI3K) (18) . Because nonclassical ER␣ signaling and activated PAK1 share common effects on neuronal morphology (19) , and because E 2 can activate PAK1 through nonclassical mechanisms (20) , we tested the hypothesis that the nonclassical negative feedback actions of E 2 are conveyed in part via ER␣-mediated activation of PAK1.
Results

E2
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of phosphorylated PAK1 immunoreactivity (pPAK1-Ir) cells in both subdivisions of the MPN. Micrographs of representative sections from 1 oil-treated and 1 EB-treated ovariectomized (OVX) rat 0.5 h after injections are given in Fig. 1A , demonstrating a greater number of pPAK1-Ir cells in the MPNl and MPNm of an EB-treated versus an oil-treated rat. Fig. 1 B and C summarizes pPAK1-Ir cell counts in the MPNl and MPNm for the 2 treatment groups at all time points. EB significantly increased the number of pPAK1-Ir cells as early as 0.5 h in the MPNl (P Ͻ 0.001; Fig. 1B ) and MPNm (P Ͻ 0.05; Fig. 1C ). This increase was maintained at 1 h after EB treatment (P Ͻ 0.01; Fig.  1 B and C) . The number of pPAK1-Ir cells at 2 and 4 h was not significantly different from corresponding values in oil-treated controls. In the same OVX animals, the oil and EB treatments were without effect on the number of pPAK1-Ir cells in the AN. Representative tissue sections containing the AN from an oil-treated and an EB-treated rat are provided in Fig. 2A , along with the summary data of pPAK1-Ir cell counts for the 2 treatments at each time point (Fig. 2B) . No significant differences between the treatment groups were observed for the pPAK1-Ir cell number in the AN at any time point.
Nonclassical ER␣ Signaling Mediates Rapid E2 Induction of pPAK1-Ir.
ER␣ can mediate negative feedback actions of E 2 by nonclassical signaling mechanisms, and rapid, nonclassical ER␣-mediated activation of PAK1 has been shown to occur in breast cancer cells (17) . We therefore sought to determine whether nonclassical ER␣ signaling mediates PAK1 activation in preoptic cells. To assess the role of nonclassical ER␣ signaling, we compared the ability of 1 g of EB to induce pPAK1-Ir in the preoptic areas of ER␣ ϩ/ϩ , ER␣ Ϫ/ Ϫ , and ER␣ Ϫ/AA mice within 1 h of treatment. Consistent with our findings in OVX rats, acute E 2 treatment induced a significant increase in the number of pPAK1-Ir cells within 1 h in the MPNl and MPNm in OVX wild-type ER␣ ϩ/ϩ mice (P Ͻ 0.01; Fig. 3 B and C) . This effect was completely absent in the ER␣ Ϫ/Ϫ mice ( Fig. 3 B and C) , confirming the obligatory involvement of ER␣ in E 2 -mediated action. In the OVX ER␣ Ϫ/AA mice, the ability of E 2 to induce PAK1 was restored to levels observed in the ER␣ ϩ/ϩ mice (P Ͻ 0.05; Fig.  3 B and C), indicating that nonclassical ER␣ signaling is sufficient to mediate E 2 effects on pPAK1 in the MPN. Representative photomicrographs of pPAK1-Ir in the MPN of the 3 genotypes are provided in Fig. 3A . The summary values for pPAK1-Ir in the 3 genotypes are depicted in Fig. 3 B and C. In contrast to the effects of E 2 in the preoptic area, E 2 was without any effect on pPAK1-Ir in the AN in any of the groups (Fig. 4) .
Nonclassical ER␣ Signaling Mediates Rapid Negative Feedback Actions of E 2.
If E 2 can rapidly activate pPAK1 through nonclassical ER␣ signaling, and this mechanism is integral to E 2 negative feedback, then it should be true that E 2 can engage this mechanism to effect a rapid suppression of LH secretion. We therefore tested the ability of acute EB injections to rapidly suppress LH by nonclassical ER␣ signaling. To examine the rapid feedback actions of E 2 on LH release, ER␣ ϩ/ϩ , ER␣ Ϫ/Ϫ , and ER␣ Ϫ/AA female mice were ovariectomized, and 7 days later (1,000-1,200 h) they received s.c. injections of 1 g of EB or oil vehicle. Animals were killed 1 h after the injection. A total of 3 blood samples were collected from each mouse-one at the time of OVX, one just before the EB injection, and one at sacrifice 1 h later. LH RIA of the plasma samples revealed that LH levels before OVX were low in ER␣ ϩ/ϩ , slightly elevated in ER␣ Ϫ/AA , and greatly increased in ER␣ Ϫ/ Ϫ mice, as reported previously (7). The serum LH levels were significantly elevated in both ER␣ ϩ/ϩ (P Ͻ 0.001; Fig. 5 , a) and ER␣ Ϫ/AA (P Ͻ 0.05; Fig. 5 , b) mice at 7 days after OVX compared with pre-OVX levels. In contrast, LH levels in ER␣ Ϫ/Ϫ mice were elevated before OVX and remained at these levels at 7 days after OVX. Treatment of OVX ER␣ ϩ/ϩ mice with EB resulted in a suppression of LH within 1 h, whereas the same treatment was without effect in the OVX ER␣ Ϫ/Ϫ mice. In the OVX ER␣ Ϫ/AA mice, EB suppressed LH to the pre-OVX levels (P Ͻ 0.05; Fig. 5, d ). The inhibitory action of EB in OVX ER␣ Ϫ/AA mice constituted Ϸ70% of the suppression seen in the OVX ER␣ ϩ/ϩ mice (P Ͻ 0.001; Fig. 5, c) .
Inhibition of PAK Phosphorylation Blocks Acute EB Suppression of LH
Secretions. Within the PAK kinases, a conserved, proline-rich sequence of 18 aa called PAK18 binds tightly to the SH3 domain of PAK-interacting exchange factor (PIX). The PIX-PAK interaction was shown to be essential for PAK activation (21) . The PAK18 peptide has been used to interfere selectively with the activation of PAKs 1-3 in cell cultures (22) (23) (24) (25) (26) and in vivo in the rat forebrain (22) . PAK18 was conjugated to a cell-permeant HIV-1 TAT peptide sequence, which has been used to deliver functional biomolecules into cells (27) . The TAT-facilitated cellular translocation has been shown to happen very rapidly (within 1-2 h) and results in neurofunctional effects in vitro and in vivo (28, 29) . The PAK18 peptide but not the inactive peptide PAK18 R192A has been shown to reduce pPAK levels in the hippocampus by 80% after intracerebroventricular (icv) treatments, an effect that was accompanied by drebrin loss, cofilin pathology, and memory deficits (22) . This suggests that PAK18 and PAK18 R192A are valid tools for inhibiting PAKs. We first verified the ability of PAK18 to block PAK phosphorylation by using hypothalamic GT1-7 cells in vitro. Western blot analysis of pPAK demonstrated that inhibition of PAK phosphorylation is rapid and significant when these cells are incubated with the peptide PAK18 (10 M) for 1 h compared with R192A (P Ͻ 0.05; Fig. 6A ). Subsequently, we infused peptide PAK18 (6 g/L, 1 L/min in 5 min) or R192A in the lateral ventricle of OVX rats. The cerebrospinal fluid (CSF) volume was 250 L per rat, with a physiological flow rate of 2.9 L min Ϫ1 (30); therefore, the concentration of PAK18 and R192A in the CSF was Ϸ10 M 1 h after the infusion, a dose found effective in vitro. Immediately after the peptide infusion, OVX animals were given an s.c. injection of EB (30 g per rat) . At 1 h after EB injection, animals were killed, and brains were removed rapidly to assess the ability of PAK18 to reduce pPAK1-Ir by immuno- 
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histofluorescence, indicating a suppression of PAK1 phosphorylation. As depicted in Fig. 6B , infusion of PAK18 peptide for 1 h resulted in a significant reduction in the number of pPAK1-Ir cells in the preoptic area compared with the control treatment (P Ͻ 0.01; Fig. 6B ). To determine the effects of PAK18 infusions on responsiveness to the negative feedback actions of E 2 , blood samples were obtained just before infusions and at autopsy 1 h after the EB treatment. Analysis of serum LH levels by RIA revealed that in OVX rats, 5-min icv infusion of PAK18 but not control peptide R192A blocked rapid suppression of serum LH 1 h after EB administration (Fig. 7) .
Discussion
Our laboratories recently demonstrated that the majority of E 2 negative feedback actions in the mouse can be exerted by a nonclassical ER ␣ signaling mechanism that proceeds in the absence of direct binding of ER␣ to EREs in the promoters of target genes (7) . In the present study, we have further determined that these inhibitory effects can occur within 1 h of E 2 administration, and thus are likely exerted via nongenotropic signaling mechanisms. Our findings specifically implicate the PAKs as components of the nongenotropic ER␣ signaling pathways leading to the suppression of GnRH and LH, because they show that (i) E 2 rapidly induces PAK1 phosphorylation in the MPN, (ii) nonclassical ER␣ signaling is sufficient to rescue rapid phosphorylation of PAK1 in preoptic cells, as well as suppression of LH secretion in ER␣-null mutants, and (iii) acute inhibition of PAK phosphorylation in preoptic-hypothalamic areas blocks the acute negative feedback actions of E 2 . The involvement of a nongenotropic mechanism in E 2 negative feedback has long been suspected, given the ability of acute E 2 treatments to suppress LH secretion in as little as 20 min (31). Although rapid steroid hormone effects on gene transcription are known, the rapid (Ͻ60 min) modulation of LH by E 2 occurs within a temporal window that is generally held to be too short to additionally include RNA processing, translation, posttranslational enzymatic processing, intracellular transport, and neurosecretion. A variety of membrane-integrated or membraneassociated receptors and cell signaling mechanisms have instead been suggested to mediate at least some of the E 2 effects on GnRH and LH. Classic work by Kelly et al. (62) revealed rapid effects of E 2 on neuronal firing in preoptic neurons that were best explained by activation of membrane receptors for E 2 . Further work demonstrated that GnRH neurons themselves are rapidly hyperpolarized by E 2 , even during tetrodotoxin-induced blockade of synaptic inputs (32), suggesting direct electrophysiological suppression through membrane-associated receptors in GnRH neurons. The absence of ER␣ in GnRH neurons has led some to suggest that rapid, direct effects of E 2 on GnRH neurons may be mediated by ER␤ (33) and/or an unidentified G proteincoupled receptor (34) . It has remained unclear, however, to what degree the rapid electrophysiological effects of E 2 on GnRH neuronal activity in vitro may reflect the operation of negative feedback loop governing GnRH neurosecretion in vivo. Our studies clearly implicate the ER␣ isoform, which is not expressed in GnRH neurons, in the rapid feedback actions of E 2 in vivo, and thus alternatively suggest an indirect mechanism conveyed via ER␣-expressing afferents to GnRH neurons. The direct ER␣-independent effects of E 2 on GnRH neurons may provide additional components of negative feedback control of GnRH and LH release, or they may function to regulate other aspects of GnRH neuronal function. We also cannot exclude the possibility that ER␣-dependent mechanisms may up-regulate ER␣-independent E 2 signaling through other receptors, which may in turn mediate E 2 feedback effects.
Rapid inhibition of LH secretion can also occur via direct suppression of gonadotrope responsiveness to GnRH (35) . It does not appear to be the case, however, that the nonclassical ER␣ signaling mechanisms described in the present studies are mediated by any such direct actions on the gonadotrope; pituitary responsiveness to GnRH is not enhanced in ER␣-null mutants (3), nor is it reduced by E 2 in ER␣ Ϫ/AA mice (7). We have also determined that nonclassical ER␣ signaling fails to rescue E 2 effects on LH mRNA and pituitary LH content (36), even as it does effectively restore the majority of E 2 suppression of LH secretion (7) . Taken together, the weight of the foregoing evidence suggests that the majority of the rapid, nonclassical ER␣-mediated suppression of LH secretion occurs through inhibitory actions on afferents to GnRH neurons. These effects are also complemented by classical, ERE-mediated transcriptional effects, because a residual 30% of E 2 negative feedback actions are not rescued by nonclassical ER␣ signaling. As reported by Christian et al. (63) , the portion of preopticohypothalamic negative feedback that is conveyed by classical ER␣ signaling may be mediated by suppression of GnRH neuronal firing.
We have observed that E 2 induces rapid phosphorylation of PAK1 in MPN cells through a nonclassical ER␣ signaling mechanism, and that the inhibition of PAK1 in the basal forebrain blocks the inhibition of LH secretion, presumably by preventing E 2 suppression of GnRH neurosecretion. Our findings are therefore consistent with the hypothesis that PAK activation in preoptic neurons mediates the negative feedback actions of E 2 on GnRH release. Although these results do not reveal the cellular signaling pathways that mediate E 2 activation of PAK1, the rapidity of this . 7 . Inhibition of PAK phosphorylation blocks acute E2 suppression of LH secretions. The LH level was significantly decreased at 1 h after R192A icv infusion and EB s.c. injection. In the contrast, the LH level was not significantly altered by treatment with PAK18 and EB (n ϭ 4 -6). Data are represented as the mean Ϯ SEM ( *** , P Ͻ 0.001; * , P Ͻ 0.05).
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process effectively limits the possibilities to those that are initiated at the plasma membrane or within the cytoplasm and that are independent of transcriptional modulation. The actions of E 2 in MPN cells parallel those observed previously in breast cancer cells, where E 2 was found to activate PAK1 through a rapid, nontranscriptional mechanism. A number of kinases have been reported to phosphorylate PAK1 and regulate its activity (37) , including the cyclin B-bound Cdc2, which phosphorylates PAK1 at Thr-212, a site also targeted by the p35-bound form of Cdk5, a neuron-specific protein kinase (38, 39) . Moreover, extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation of PAK1 at Thr-212 (40) . PAK1 is also known to function as an effector protein of PI3K (18, 41) . In the present study, ER␣ signaling was found to induce rapid phosphorylation of PAK1 at Thr-212 in MPN cells. Because E 2 can rapidly influence MAPK/ ERK and PI3K/Akt signaling pathways in a variety of cell types (42, 43) and in a variety of brain regions, including the MPN (44), it is possible that ER␣ signaling induces phosphorylation of PAK1 by ER␣-mediated activation of either or both intermediate signaling kinases.
Consistent with the hypothesis that PAK1 mediates E 2 feedback effects, recent studies have revealed that many of the cellular actions of E 2 in the CNS are shared by those of activated PAK1. Both activated PAK1 (23) and ER␣ signaling (15, 45, 46) can induce rapid alterations in the dendritic cytoskeleton that are integral to morphological plasticity in central neurons. In cortical neurons, PAK1 activity promotes formation and maintenance of dendritic spines (47) . A recent study showed that E 2 also rapidly increases the number of nascent dendritic spines in cortical neurons (46) , and thereby acutely increases neuronal connectivity, although these effects appear to be exerted in an ER␣-independent manner. Estradiol also stimulates dendritic spinogenesis in hippocampal CA1 neurons, an effect that may occur rapidly via activation of ER␣ and MAPK signaling (45) . Previous studies have also documented that E 2 induces synaptic remodeling in the ventromedial nucleus, the anteroventral periventricular nucleus, the MPN, and the AN of the hypothalamus (10, 14) .
Because ER␣ signaling and PAKs can both mediate rapid actin cytoskeletal organization and morphological plasticity (11, 23, (48) (49) (50) (51) , it is thus possible that these downstream cellular events comprise a major route by which E 2 -activated PAKs may mediate negative feedback control over GnRH and, hence, LH secretion. It remains to be determined whether such a rapid, PAK-mediated alteration in cell connectivity functions in this manner and, if so, which of the many known PAK substrates (e.g., actin-related protein 2/3 complex, filamin, and/or cofilin) (19) may mediate these actions. Further studies will also be necessary to identify the ER␣-expressing cell populations in which PAKs mediate these E 2 effects. The absence of ER␣ expression in GnRH neurons (52) makes it unlikely that the ER␣-mediated negative feedback mechanism that we have characterized in these studies operates within GnRH neurons themselves. Expression of ER␣ does occur in GABAergic neurons, including those that appear to be afferents to GnRH neurons (53) , and GABA release is modulated by E 2 in a variety of brain regions. Moreover, ER␣ has been shown recently to be localized to axon terminals in hippocampal GABAergic interneurons (54, 55) , suggesting their involvement in nongenotropic modulation of synaptic function. The localization of ERs to dendrites and axon terminals has been shown previously in hypothalamic neurons as well (56) . Herbison and colleagues (57) have also recently characterized a nonclassical ER␣ signaling mechanism that mediates E 2 modulation of GABAergic transmission on GnRH neurons.
Taken together, our findings support a model for the homeostatic negative feedback actions of E 2 wherein the activation of extranuclear ER␣ is coupled via one or more cytoplasmic kinase signaling cascades to the activation of PAKs. Activated PAKs, which would presumably include the brain-enriched PAK1, thereafter mediate alterations in cell function and/or connectivity in neural circuitries that govern GnRH neurosecretion, and thereby suppress the release of the GnRH decapeptide into the hypophysial portal vasculature. Although several of the specific features of this model await testing, the present results provide initial evidence in a physiological context that nonclassical ER␣ signaling, leading to the activation of one or more of the PAKs, is a signaling pathway that is integral to the manifestation of physiological E 2 negative feedback control in the reproductive axis.
Materials and Methods
Animals. The ER␣ Ϫ/ Ϫ and ER␣ Ϫ/AA mutant mice were generated as described (6, 58, 59) . Further details appear in SI Materials and Methods.
Effects of EB Treatment on PAK1 Phosphorylation. Rats and mice were anesthetized and bilaterally OVX. On the morning of day 7 after OVX (0800 -1000 hours), animals were given an s.c. injection of sesame oil vehicle or EB (10 g per rat; 1 g per mouse). Animals were anesthetized with 75 mg/kg i.p. ketamine (Fort Dodge Laboratories) and 5 mg/kg i.p. xylazine (Burns Veterinary Supply Inc.) and transcardially perfused with 4% paraformaldehyde (Sigma), pH 7.4, at the following time points after injection: 0.5, 1, 2, or 4 h for rats; 1 h for mice (60) . Further details appear in SI Materials and Methods.
Effects of OVX and Acute EB Treatment on LH Release. Female mice 2-4 months of age were anesthetized (0800 -1000 hours), and blood samples were collected immediately before OVX. At 7 days after OVX, blood samples were obtained, and either 1 g of EB or sesame oil vehicle injections was administered s.c. At 1 h after injections, blood samples were obtained by exsanguination following cardiac puncture. Further details appear in SI Materials and Methods.
Effects of PAK18 Inhibitory Peptide on EB Suppression of LH Release. Details of stereotaxic surgery, PAK18 inhibitory peptide infusion, EB treatment, and blood sample collection can be found in SI Materials and Methods.
Cell Culture and Western Blot Analysis. The effectiveness of the PAK18 peptide in suppressing PAK phosphorylation was tested in GT1-7 cells, an immortalized GnRH-producing cell line (61) . Further details appear in SI Materials and Methods.
Immunohistochemistry and Analysis. Brain sections were processed for immunohistochemistry following standard procedures. Details can be found in SI Materials and Methods.
Additional experimental procedures are presented in SI Materials and Methods.
